Drugs / HBsAg vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01813487 | Feb → Jul 2013 | chronic hepatitis B virus infection | Genexine, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HBsAg vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01813487 ↗ |
| Modality | Vaccine | “HBsAg Vaccine” NCT01813487 ↗ |